Collectively, we identify IL3RA as a direct downstream target of EP300-ZNF384, suggesting CD123 is a potent biomarker for EP300-ZNF384-driven B-ALL. The gene discussed is IL3RA; the disease is precursor B-cell acute lymphoblastic leukemia.